DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Supriya Lifescience
03 2AFT Pharmaceuticals
04 4Accord healthcare
05 1Apotex Inc
06 1Aspiro Pharma
07 1Aurobindo Pharma Limited
08 1Baxter Healthcare Corporation
09 2Biological E
10 1Chia Tai Tianqing Pharmaceutical Group
11 1Cipla Medpro South Africa
12 1Etico Lifesciences
13 1Fresenius Kabi USA
14 1GENEYORK PHARMS
15 1Grupo Azevedos
16 1Hikma Pharmaceuticals
17 2Juno Pharmaceuticals Pty Ltd
18 1Lupin Ltd
19 1MERCK CANADA INC
20 2MSD INTL GMBH
21 1MSN Laboratories
22 2Medsurge Healthcare
23 7Merck & Co
24 1Naprod Life Sciences
25 1Navinta
26 1Piramal Enterprises Limited
27 1Polifarma
28 1Praxgen
29 1Qilu Pharmaceutical
30 2Reach Pharmaceuticals
31 1Sagent Pharmaceuticals
32 1Sakar Healthcare
33 1Sandoz B2B
34 1Steriscience
35 1Tarbis Farma Sl
36 2Tecnimede
37 1Teva Pharmaceutical Industries
38 1TherDose Pharma
39 2Viatris
40 1Zentiva
01 1Fosaprepitant 150Mg 10 Ml 1 Units Parenteral Use
02 2INF
03 2INJ
04 3Injection
05 1Lyophilised Injection
06 1Lyophilized Injection
07 2POWDER FOR SOLUTION
08 22POWDER;INTRAVENOUS
09 1Powder For Infusion Solution
10 5Powder For Solution For Infusion
11 1Powder for Solution for Injection
12 1Powder for solution for Infusion
13 1Powder for solution for infusion
14 1SOLUTION;INTRAVENOUS
15 3Solution For Injection
16 1UNKNOWN
17 1Vial
18 8Blank
01 2Approved
02 6Authorized
03 9DISCN
04 1Deregistered
05 3Generic
06 1Originator
07 2Prescription
08 14RX
09 19Blank
01 2EMEND
02 1EMEND IV
03 1EMETEND 150 mg
04 1Easan
05 2Emend IV
06 1FOCINVEZ
07 21FOSAPREPITANT DIMEGLUMINE
08 1FOSAPREPITANT FOR INJECTION
09 2FOSAPREPITANT MEDSURGE
10 2FOSAPREPITANT MSN
11 2FOSAPREPITANT-AFT
12 2Fosaprepitant Accord
13 1Fosaprepitant Cipla
14 1Fosaprepitant Hikma
15 1Fosaprepitant Tarbis
16 1Fosaprepitant Tecnigen
17 1Fosaprepitant Zentiva
18 1IVEMEND 150 mg
19 1Item
20 3Ivemend
21 9Blank
01 8Australia
02 2Canada
03 6India
04 1Italy
05 2Portugal
06 4South Africa
07 6Spain
08 3Sweden
09 1Turkey
10 24USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-12-09
Application Number : 211160
Regulatory Info : RX
Registration Country : USA
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-08-26
Application Number : 204025
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 205020
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2021-01-12
Application Number : 210625
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 211860
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 212309
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2021-03-03
Application Number : 212143
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2016-06-09
Application Number : 206197
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 210689
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EMEND
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-01-25
Application Number : 22023
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMEND
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2010-11-12
Application Number : 22023
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 209965
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-08-20
Application Number : 212957
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : UNKNOWN
Dosage Strength : UNKNOWN
Packaging :
Approval Date :
Application Number : 204845
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-12-08
Application Number : 203939
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 210064
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 115MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 204015
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 204015
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 211624
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
